(MedPage Today) — PHOENIX — A first-in-class oral miR-124 enhancer significantly improved clinical remission and endoscopic outcomes for patients with moderately to severely active ulcerative colitis (UC) who had failed multiple prior therapies…
Source link : https://www.medpagetoday.com/meetingcoverage/acg/118244
Author :
Publish date : 2025-10-30 20:24:00
Copyright for syndicated content belongs to the linked Source.
